• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无淋巴结转移的食管鳞状细胞癌患者的切除淋巴结数量与生存状态:一项队列研究

Number of Resected Lymph Nodes and Survival Status in Node-Negative Esophageal Squamous Cell Carcinoma: A Cohort Study.

作者信息

Lu Yifei, Ye Minhua, Ma Dehua, Chen Yu

机构信息

Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, People's Republic of China.

Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, People's Republic of China.

出版信息

Int J Gen Med. 2024 Oct 14;17:4633-4643. doi: 10.2147/IJGM.S480893. eCollection 2024.

DOI:10.2147/IJGM.S480893
PMID:39429965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11488356/
Abstract

OBJECTIVE

To explore the association between survival status and the number of resected lymph nodes in node-negative esophageal squamous cell carcinoma(ESCC) after surgical treatment.

METHODS

This was a retrospective observational cohort study and data were obtained from the Surveillance, Epidemiology, and End Results program (SEER) and TaiZhou hospital in China. The data for subjects with negative lymph nodes and no distant metastasis (pN0M0) after post-operative pathology were screened. The nonlinear relationship between resected lymph node number and survival status in node-negative ESCC was conducted using restricted cubic spline regression analysis. The association between the number of resected lymph nodes and survival status in node-negative ESCC was evaluated by Cox proportional hazards regression models. Subgroup analysis based on different subgroups was also performed.

RESULTS

A total of 999 subjects were included in the study. Restricted cubic spline regression was used to show a U shaped association between the number of resected lymph nodes and survival status in node-negative ESCC, with low count associated with a decreased survival. To elucidate the association, we adjusted for age, sex, race, T stage, TNM (tumor node metastasis classification), location, grade, chemotherapy, and radiotherapy. As the resected lymph node number increased by one node, the survival status was improved by 2% (Hazard ratio(HR) = 0.98, 95% confidence interval (CI) 0.98-0.99). Sensitivity analysis indicate that the effect size and direction in different subgroups are consistent, the results is stability in SEER.

CONCLUSION

A low count of resected lymph nodes correlated with reduced survival in patients with ESCC, where resecting 25 to 28 or more nodes is considered optimal. Larger prospective studies are warranted to confirm these findings.

摘要

目的

探讨手术治疗后淋巴结阴性的食管鳞状细胞癌(ESCC)患者的生存状况与切除淋巴结数量之间的关联。

方法

这是一项回顾性观察队列研究,数据来自美国监测、流行病学和最终结果计划(SEER)以及中国台州医院。筛选术后病理显示淋巴结阴性且无远处转移(pN0M0)患者的数据。采用受限立方样条回归分析淋巴结阴性ESCC患者切除淋巴结数量与生存状况之间的非线性关系。通过Cox比例风险回归模型评估淋巴结阴性ESCC患者切除淋巴结数量与生存状况之间的关联。还进行了基于不同亚组的亚组分析。

结果

本研究共纳入999名受试者。采用受限立方样条回归分析显示,淋巴结阴性ESCC患者切除淋巴结数量与生存状况呈U形关联,切除淋巴结数量少与生存率降低相关。为阐明这种关联,我们对年龄、性别、种族、T分期、TNM(肿瘤淋巴结转移分类)、位置、分级、化疗和放疗进行了校正。随着切除淋巴结数量增加1个,生存状况改善2%(风险比(HR)=0.98,95%置信区间(CI)0.98 - 0.99)。敏感性分析表明,不同亚组的效应大小和方向一致,SEER中的结果具有稳定性。

结论

ESCC患者切除淋巴结数量少与生存率降低相关,切除25至28个或更多淋巴结被认为是最佳的。需要更大规模的前瞻性研究来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/7e78922c2668/IJGM-17-4633-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/ba554c0fd782/IJGM-17-4633-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/1a1229de0db0/IJGM-17-4633-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/022e60ebf2fe/IJGM-17-4633-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/7e78922c2668/IJGM-17-4633-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/ba554c0fd782/IJGM-17-4633-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/1a1229de0db0/IJGM-17-4633-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/022e60ebf2fe/IJGM-17-4633-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea42/11488356/7e78922c2668/IJGM-17-4633-g0004.jpg

相似文献

1
Number of Resected Lymph Nodes and Survival Status in Node-Negative Esophageal Squamous Cell Carcinoma: A Cohort Study.无淋巴结转移的食管鳞状细胞癌患者的切除淋巴结数量与生存状态:一项队列研究
Int J Gen Med. 2024 Oct 14;17:4633-4643. doi: 10.2147/IJGM.S480893. eCollection 2024.
2
The number of resected lymph nodes from the upper mediastinal area predicts long-term outcomes of esophageal squamous cell carcinoma after minimally invasive esophagectomy.上纵隔区切除的淋巴结数目可预测微创食管切除术治疗食管鳞癌的长期预后。
Surg Endosc. 2024 Jul;38(7):3625-3635. doi: 10.1007/s00464-024-10853-4. Epub 2024 May 20.
3
Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma.淋巴结清扫数目与食管鳞癌患者术后生存相关。
Surgery. 2013 Feb;153(2):234-41. doi: 10.1016/j.surg.2012.08.001. Epub 2012 Sep 12.
4
Impact of the number of resected lymph nodes on postoperative survival of patients with node-negative oesophageal squamous cell carcinoma.淋巴结清扫数目对淋巴结阴性食管鳞癌患者术后生存的影响。
Eur J Cardiothorac Surg. 2013 Oct;44(4):631-6. doi: 10.1093/ejcts/ezt097. Epub 2013 Mar 10.
5
Prognostic impact of lymph node harvest for patients with node-negative esophageal squamous cell carcinoma: a large-scale multicenter study.淋巴结清扫对淋巴结阴性食管鳞状细胞癌患者的预后影响:一项大规模多中心研究。
J Gastrointest Oncol. 2021 Oct;12(5):1951-1962. doi: 10.21037/jgo-20-371.
6
Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.淋巴结阴性食管鳞状细胞癌患者切除淋巴结数量的预后价值
Int J Clin Exp Pathol. 2020 Mar 1;13(3):597-606. eCollection 2020.
7
Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.病理分期 T1-3N0M0 的食管鳞癌中检查淋巴结数量对术后生存的影响。
BMC Cancer. 2022 Jan 28;22(1):118. doi: 10.1186/s12885-022-09207-x.
8
The Least Nodal Disease Burden Defines the Minimum Number of Nodes Retrieved for Esophageal Squamous Cell Carcinoma.最低淋巴结疾病负担决定了食管鳞状细胞癌切除淋巴结的最少数量。
Front Oncol. 2022 Mar 3;12:764227. doi: 10.3389/fonc.2022.764227. eCollection 2022.
9
Alcohol and survival in ESCC: prediagnosis alcohol consumption and postoperative survival in lymph node-negative esophageal carcinoma patients.酒精与食管鳞状细胞癌的生存:淋巴结阴性食管癌患者诊断前饮酒情况与术后生存
Oncotarget. 2016 Jun 21;7(25):38857-38863. doi: 10.18632/oncotarget.8754.
10
Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy.左胸入路食管癌切除术患者检查淋巴结数对食管鳞癌的影响。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1956-1962. doi: 10.1016/j.ejso.2020.04.047. Epub 2020 May 4.

本文引用的文献

1
Do Nodal Disease Patterns and Approach to Lymphadenectomy Affect Survival in Patients with Esophageal Squamous Cell Carcinoma? Reinvigorating an Age-Old Debate.淋巴结疾病模式及淋巴结清扫方式对食管鳞状细胞癌患者的生存有影响吗?重拾一场古老的争论。
Ann Surg Oncol. 2024 Jun;31(6):3584-3586. doi: 10.1245/s10434-024-15176-1. Epub 2024 Mar 17.
2
The STROCSS 2024 guideline: strengthening the reporting of cohort, cross-sectional, and case-control studies in surgery.STROCSS 2024 指南:加强外科手术中队列研究、横断面研究和病例对照研究的报告。
Int J Surg. 2024 Jun 1;110(6):3151-3165. doi: 10.1097/JS9.0000000000001268.
3
Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis.
pN1 期食管鳞癌患者转移淋巴结对生存的影响:长期生存分析。
Ann Surg Oncol. 2024 Jun;31(6):3794-3802. doi: 10.1245/s10434-024-15019-z. Epub 2024 Feb 19.
4
Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.增加切除的淋巴结站数可提高食管鳞状细胞癌的生存率。
BMC Cancer. 2024 Feb 5;24(1):177. doi: 10.1186/s12885-024-11886-7.
5
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study.食管鳞癌患者的淋巴结切除与生存:一项观察性研究。
Int J Surg. 2023 Jul 1;109(7):2001-2009. doi: 10.1097/JS9.0000000000000436.
6
Patterns and Influence of Lymph Nodal Metastases After Neoadjuvant Chemotherapy and Surgery for Thoracic Esophageal Squamous Cell Carcinoma.新辅助化疗和手术治疗胸段食管鳞癌后淋巴结转移的模式和影响。
Ann Surg Oncol. 2023 Aug;30(8):5205-5212. doi: 10.1245/s10434-023-13634-w. Epub 2023 May 10.
7
Survival impact of the number of lymph nodes dissection in patients receiving neoadjuvant chemotherapy for esophageal squamous cell carcinoma.新辅助化疗治疗食管鳞癌患者淋巴结清扫数目对生存的影响。
Dis Esophagus. 2023 Apr 29;36(5). doi: 10.1093/dote/doac082.
8
Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinoma.新辅助放化疗和 R0 切除术后食管腺癌淋巴结转移的模式和影响。
J Thorac Cardiovasc Surg. 2022 Aug;164(2):411-419. doi: 10.1016/j.jtcvs.2021.11.094. Epub 2022 Mar 1.
9
Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.淋巴结清扫对局部晚期食管鳞状细胞癌新辅助放化疗后生存的影响:来自多中心随机研究NEOCRTEC5010的结果
Ann Surg. 2023 Feb 1;277(2):259-266. doi: 10.1097/SLA.0000000000004798. Epub 2023 Jan 10.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.